Skip to main content

Hydrocortisone Suppository Prescribing Information

Package insert / product label
Generic name: hydrocortisone acetate
Dosage form: rectal suppository
Drug class: Topical steroids

Medically reviewed by Drugs.com. Last updated on Nov 9, 2023.

On This Page
  • Description
  • Clinical Pharmacology
  • Indications and Usage
  • Contraindications
  • Precautions
  • Adverse Reactions/Side Effects
  • Drug Abuse and Dependence
  • Dosage and Administration
  • How Supplied/Storage and Handling

Hydrocortisone Suppository Description

Each Hydrocortisone Acetate Suppository for rectal administration contains hydrocortisone acetate USP in a hydrogenated palm kernel oil base.

Hydrocortisone acetate is a corticosteroid. The molecular weight of hydrocortisone acetate is 404.50. Chemically, hydrocortisone acetate is pregn-4-ene-3, 20 dione, 21- (acetyloxy)-11, 17-dihydroxy-, (11尾)- with an empirical formula of C23 H32O6 and the following structural formula:

struct

Hydrocortisone Suppository - Clinical Pharmacology

In normal subjects, about 26 percent of hydrocortisone acetate is absorbed when the hydrocortisone acetate suppository is applied to the rectum. Absorption of hydrocortisone acetate may vary across abraded or inflamed surfaces.

Topical steroids are primarily effective because of their anti-inflammatory, antipruritic and vasoconstrictive action.

Indications and Usage for Hydrocortisone Suppository

Hydrocortisone Acetate Suppositories are indicated for use in inflamed hemorrhoids, post irradiation (factitial) proctitis, as an adjunct in the treatment of chronic ulcerative colitis, cryptitis, other inflammatory conditions of the anorectum, and pruritus ani.

Contraindications

Hydrocortisone Acetate Suppositories are contraindicated in those patients with a history of hypersensitivity to any of the components.

Precautions

Do not use unless adequate proctologic examination is made.

If irritation develops, the product should be discontinued, and appropriate therapy instituted.

In the presence of an infection, the use of an appropriate antifungal or antibacterial agent should be instituted. If a favorable response does not occur promptly, Hydrocortisone Acetate Suppositories should be discontinued until the infection has been adequately controlled.

Carcinogenesis

No long-term studies in animals have been performed to evaluate the carcinogenic potential of corticosteroid suppositories.

PREGNANCY CATEGORY C

In laboratory animals, topical steroids have been associated with an increase in the incidence of fetal abnormalities when gestating females have been exposed to rather low dosage levels. There are no adequate and well-controlled studies in pregnant women.

Hydrocortisone acetate suppositories should only be used during pregnancy if the potential benefit justifies the risk to the fetus. Drugs of this class should not be used extensively on pregnant patients, in large amounts, or for prolonged periods of time.

It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants from hydrocortisone acetate suppositories, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.

Adverse Reactions/Side Effects

The following local adverse reactions have been reported with Hydrocortisone Acetate Suppositories: burning, itching, irritation, dryness, folliculitis, hypopigmentation, allergic contact dermatitis, and secondary infection.

To report SUSPECTED ADVERSE REACTIONS, contact Marlex Pharmaceuticals at 1-888-582-1953 or drugsafety@marlexpharm.com or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Drug Abuse and Dependence

Drug abuse and dependence have not been reported in patients treated with Hydrocortisone Acetate Suppositories.

Hydrocortisone Suppository Dosage and Administration

For rectal administration: Insert one suppository in the rectum twice daily, morning and night for two weeks, in nonspecific proctitis.ln more severe cases, one suppository three times a day or two suppositories twice daily. In factitial proctitis, the recommended duration of therapy is six to eight weeks or less, according to the response of the individual case.

Detach and hold one suppository upright(point upward). Separate tabs at top opening and pull downward to almost the full length of the suppository. Carefully remove the suppository, avoiding excessive handling, which is designed to melt at body temperature. Insert suppository into the rectum, pointed end first, with gentle pressure.

How is Hydrocortisone Suppository supplied

25mg (12 count) NDC 10135-0751-12

25mg (24 count) NDC 10135-0751-24

Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Store away from heat. Protect from freezing.

Manufactured for/ Distributed by:

Marlex Pharmaceuticals, Inc.

New Castle, DE 19720

Rev. 07/22 ID

PRINCIPAL DISPLAY PANEL - 25 mg Suppository Carton

NDC 10135-0751-12

Rx Only

Hydrocortisone Acetate
Suppositories

25 mg

FOR RECTAL USE ONLY

12 Suppositories

12-count

PRINCIPAL DISPLAY PANEL - 25 mg Suppository Carton

NDC 10135-0751-24

Rx Only

Hydrocortisone Acetate
Suppositories

25 mg

FOR RECTAL USE ONLY

24 Suppositories

24-count

HYDROCORTISONE ACETATE
hydrocortisone acetate suppository
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:10135-751
Route of AdministrationRECTAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
HYDROCORTISONE ACETATE (UNII: 3X7931PO74) (HYDROCORTISONE - UNII:WI4X0X7BPJ) HYDROCORTISONE ACETATE25 mg
Inactive Ingredients
Ingredient NameStrength
HYDROGENATED PALM OIL (UNII: 257THB963H)
Product Characteristics
Colorwhite ((White to Off-White)) Score
ShapeBULLETSize
FlavorImprint Code
Contains
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:10135-751-1212 in 1 CARTON; Type 0: Not a Combination Product08/01/2022
2NDC:10135-751-2424 in 1 CARTON; Type 0: Not a Combination Product08/01/2022
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other08/01/2022
Labeler - Marlex Pharmaceuticals, Inc. (782540215)

More about hydrocortisone topical

  • Check interactions
  • Compare alternatives
  • Pricing & coupons
  • Reviews (62)
  • Drug images
  • Side effects
  • Dosage information
  • During pregnancy
  • Drug class: topical steroids
  • Breastfeeding

Patient resources

  • Hydrocortisone drug information

Professional resources

  • Hydrocortisone (Topical) monograph
  • Hydrocort Lotion (FDA)
  • Hydrocortisone (FDA)
  • Hydrocortisone 2.5% (FDA)
  • Hydrocortisone Butyrate (FDA)

Other brands

Westcort, Anusol-HC Suppositories, Anucort-HC, Proctozone HC, ... +15 more

Related treatment guides

  • Anal Itching
  • Atopic Dermatitis
  • Eczema
  • Dermatitis

天下网标王成都网站关键词推广优化汕头网站首页关键词优化报价小说漫画网站做优化网站建设与优化up乚云速捷专业网站排名优化古冶区网站seo优化排名网站的tdk优化一网恒通网站优化软件茂名专业网站优化服务商惠州省钱网站优化如何做精湛的网站seo优化呼和浩特seo网站优化软件网站优化失败怎么解决网站优化协议网站关键词优化多少钱东至网站优化哪家价格实惠资深网站优化哪家好网站头部优化代码怎么优化权重4的网站江苏正规的网站seo优化推广企业网站优化推广方案优化网站推广厂家价格郑州网站优化建设怎么找网站优化软件网站搜索引擎网站优化要多少钱手机站seo网站优化seo优化网站地图无锡盐城网站优化工作室天台网站优化壹起航如何优化网站关键词香港通过《维护国家安全条例》两大学生合买彩票中奖一人不认账让美丽中国“从细节出发”19岁小伙救下5人后溺亡 多方发声卫健委通报少年有偿捐血浆16次猝死汪小菲曝离婚始末何赛飞追着代拍打雅江山火三名扑火人员牺牲系谣言男子被猫抓伤后确诊“猫抓病”周杰伦一审败诉网易中国拥有亿元资产的家庭达13.3万户315晚会后胖东来又人满为患了高校汽车撞人致3死16伤 司机系学生张家界的山上“长”满了韩国人?张立群任西安交通大学校长手机成瘾是影响睡眠质量重要因素网友洛杉矶偶遇贾玲“重生之我在北大当嫡校长”单亲妈妈陷入热恋 14岁儿子报警倪萍分享减重40斤方法杨倩无缘巴黎奥运考生莫言也上北大硕士复试名单了许家印被限制高消费奥巴马现身唐宁街 黑色着装引猜测专访95后高颜值猪保姆男孩8年未见母亲被告知被遗忘七年后宇文玥被薅头发捞上岸郑州一火锅店爆改成麻辣烫店西双版纳热带植物园回应蜉蝣大爆发沉迷短剧的人就像掉进了杀猪盘当地回应沈阳致3死车祸车主疑毒驾开除党籍5年后 原水城县长再被查凯特王妃现身!外出购物视频曝光初中生遭15人围殴自卫刺伤3人判无罪事业单位女子向同事水杯投不明物质男子被流浪猫绊倒 投喂者赔24万外国人感慨凌晨的中国很安全路边卖淀粉肠阿姨主动出示声明书胖东来员工每周单休无小长假王树国卸任西安交大校长 师生送别小米汽车超级工厂正式揭幕黑马情侣提车了妈妈回应孩子在校撞护栏坠楼校方回应护栏损坏小学生课间坠楼房客欠租失踪 房东直发愁专家建议不必谈骨泥色变老人退休金被冒领16年 金额超20万西藏招商引资投资者子女可当地高考特朗普无法缴纳4.54亿美元罚金浙江一高校内汽车冲撞行人 多人受伤

天下网标王 XML地图 TXT地图 虚拟主机 SEO 网站制作 网站优化